| Q30360645 | A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations. |
| Q52601683 | A new method for tumor imaging by targeting cancer associated fibroblasts. |
| Q28537598 | A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading |
| Q38097532 | Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma |
| Q34759911 | Breast tumor microenvironment: proteomics highlights the treatments targeting secretome |
| Q38063582 | Cancer-associated fibroblasts as targets for immunotherapy |
| Q35147285 | Comparative genome analysis of Prevotella intermedia strain isolated from infected root canal reveals features related to pathogenicity and adaptation. |
| Q90315301 | Design and development of 99mTc labeled FAPI-tracers for SPECT-imaging and 188Re therapy |
| Q33498941 | Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma |
| Q35144928 | Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy |
| Q50150752 | EMT-related Transcription Factor Snail up-regulates FAPα in Malignant Melanoma Cells |
| Q33575499 | Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent |
| Q35586530 | Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma |
| Q46526798 | FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions |
| Q33833031 | Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques |
| Q35097559 | Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation |
| Q46972223 | Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival |
| Q36269734 | Fibroblast activation protein is dispensable in the anti-influenza immune response in mice. |
| Q33311561 | Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites |
| Q28082504 | Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review) |
| Q39538239 | Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions. |
| Q35754294 | Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations |
| Q89631276 | Fibroblasts in the Tumor Microenvironment |
| Q54368368 | Gene expression in oligodendroglial tumors. |
| Q89631290 | Hepatic Stellate Cells in Liver Tumor |
| Q98178301 | High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes |
| Q34407226 | Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles |
| Q38343606 | Identification and characterization of the promoter of fibroblast activation protein |
| Q36593747 | Immune resistance orchestrated by the tumor microenvironment |
| Q43162044 | Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts |
| Q37357828 | Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease |
| Q58864225 | Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes |
| Q33993449 | Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity. |
| Q64098474 | Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy |
| Q44699380 | Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma |
| Q43045594 | Penduliflorain I: A cysteine protease isolated from Hohenbergia penduliflora (A.Rich.) Mez (Bromeliaceae). |
| Q34293605 | Peptidomics of the prolyl peptidases |
| Q37411837 | Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers |
| Q24654187 | Profiling constitutive proteolytic events in vivo |
| Q40539875 | Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy |
| Q27004215 | Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy |
| Q37948110 | Recent patents of dipeptidyl peptidase IV inhibitors |
| Q40134994 | Selective fluorescence probes for dipeptidyl peptidase activity-fibroblast activation protein and dipeptidyl peptidase IV. |
| Q39187279 | Separation and cultivation of laryngeal carcinoma-associated fibroblasts and biological influence on a laryngeal carcinoma cell line |
| Q40110840 | Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells |
| Q84613564 | Specificity of inhibitors and frequency of expression of target proteins used to study cartilage invasion by rheumatoid arthritis synovial fibroblasts: Comment on the article by Ospelt et al |
| Q58789499 | Targeting the Microenvironment in High Grade Serous Ovarian Cancer |
| Q35947656 | Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin |
| Q28073437 | The application of the fibroblast activation protein α-targeted immunotherapy strategy |
| Q33721277 | The crude skin secretion of the pepper frog Leptodactylus labyrinthicus is rich in metallo and serine peptidases |
| Q37552929 | The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer |
| Q39143305 | Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy |
| Q26829096 | Tumor heterogeneity and its implication for drug delivery |
| Q27015980 | Tumor stroma as targets for cancer therapy |
| Q45931894 | [MMP- and FAP-mediated non-inflammation-related destruction of cartilage and bone in rheumatoid arthritis]. |